ImmunoCellular Therapeutics Announces Agreement on Terms of Settlement of Federal Class Action Shareholder Lawsuit, Will Pay $1.15M Fully Funded Through An Insurance Carrier For Dismissal Of All Claims Against The Co. And Its Officers And Directors
Benzinga_Newsdesk